HawkCell

HawkCell

Animal-dedicated MRI system with AI

Overview

HawkCell Tech adapts human MRI systems for animal use in veterinary and preclinical labs by adding a plug-and-play AI layer and animal-specific hardware. It uses patent-protected, 3D-printed MRI coils and a proprietary animal positioner to customize standard MRI hardware for animals, while an AI layer denoises images, speeds acquisition, and enables new imaging sequences. The system can be operated remotely and delivers image quality that is three times clearer, applicable to about 90% of human MRI diagnoses in animals across oncology, cardiology, and surgery. This approach improves animal welfare, reduces anesthesia time and CO2 emissions, lowers animal-related costs, and boosts ROI by at least 50% for clinicians and researchers.

Significant Headcount Growth

About HawkCell

Simplify's Rating
Why HawkCell is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

11-50

Company Stage

Series A

Total Funding

$6.3M

Headquarters

Lyon, France

Founded

2018

Get referred to HawkCell

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 2025 TIME Medical deal gives immediate access to 140 installations.
  • Recent 2026 job postings for data, DevOps, and business development show active scaling.
  • Cynbiome partnership shows preclinical demand for HawkCell's large-animal MRI capabilities.

What critics are saying

  • €5 million Series A from March 2024 is small against hardware commercialization burn.
  • China partnership depends on TIME Medical execution, channel adoption, and regulatory localization.
  • HawkCell's niche could stay niche if clinics prefer incumbent MRI vendors and service contracts.

What makes HawkCell unique

  • HawkCell upgrades human MRI for animals, with dedicated coils and AI workflows.
  • TIME Medical partnership in July 2025 links HawkCell to China's veterinary MRI leader.
  • Lyon-based platform spans veterinarians and preclinical CROs, unlike single-use animal imaging startups.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$6.3M

Below

Industry Average

Funded Over

2 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Below Average

Industry standards

$15M
$5.5M
HawkCell
$8.2M
Discord
$15M
Canva
$30M
Kalshi

Growth & Insights and Company News

Headcount

6 month growth

9%

1 year growth

14%

2 year growth

9%
Brown Brothers Media
Mar 12th, 2024
French healthcare startup HawkCell bags €5M to enhance animal healthcare and preclinical research

Lyon-based HawkCell, a healthtech startup, announced that it has secured €5M in a Series A round of funding led by a German venture capital firm MIG Capital, with participation from French investment bank, Bpifrance.

LinkedIn
Mar 12th, 2024
Alexis Girin on LinkedIn: #hawkcell #mig #bpi #animalimaging #innovation #ethics #partnership | 19 comments

Absolutely thrilled that MIG Capital and Bpifrance are joining forces with HawkCell to revolutionize animal imaging—making it faster, sharper, and more… | 19 comments on LinkedIn

FinSMEs
Mar 11th, 2024
HawkCell Raises €5M in Series A Financing

HawkCell, a Lyon, France-based veterinary care and preclinical research company, raised €5M in Series A funding

FinSMEs
Mar 11th, 2024
HawkCell Raises €5M in Series A Financing

HawkCell raises €5M in Series A financing.

Recently Posted Jobs

Sign up to get curated job recommendations

HawkCell is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →